Novelty

Novelty is a requirement for patentability. An invention is not new and therefore not patentable if it was known to the public (disclosed in the prior art) before the filing date of the patent application, or, if the application claims priority of an earlier patent application, before the priority date.

Added matter, Case Law, Disclaimer, Inventive step, Norway, Novelty, Priority right, Scope of protection, Sufficiency of disclosure

/

The Borgarting Court of Appeal overturned the district court decision which revoked the patents in suit for lack of inventive step. The Court held that even if oxycodone had been known and used to treat pain as an alternative to morphine, the skilled person could not have predicted that a controlled release formulation with oxycodone…

Added matter, Denmark, EPC, European Union, Extension of subject matter, Injunction, Inventive step, Novelty, Revocation, Validity

(Bugge Valentin)/

In Denmark, a patentee may opt to apply for a utility model registration in addition to a patent, provided that the conditions for the grant of both rights are fulfilled. One of the strategic advantages of applying for both rights in Denmark is that the utility model registration is not subject to as thorough a…

EPC, Novelty, United Kingdom, Validity

(Bristows)/

As previously discussed, the English Court of Appeal has clearly stated its support for judicial collaboration facilitating de facto harmonisation of patent law in Europe (Grimme Landmaschinenfabrik GmbH v Scott [2010] EWCA Civ 1110). However, in a recent decision in the English Patents Court (Lundbeck v Norpharma and Infosint [2011] EWHC 907), Floyd J. expressed…

Extent of Protection, Germany, Novelty, Revocation, Validity

(Hoffmann Eitle)/

By final judgment of November 18, 2010 (Xa ZR 149/07, published in Mitt. 2011, 66 (in German only)), the German Federal Court of Justice (FCJ) decided on two interesting issues in nullity appeal proceedings regarding the German patent DE 101 41 650 pertaining to a patch containing the opioid fentanyl, a strong analgesic drug. Firstly,…

Case Law, Mechanical Engineering, Novelty, Opposition, Revocation, Slovenia, Validity

/

The Court held that in order to decide that a patented invention is novel, it is not sufficient that the wording in the patent description is different from the wording in the prior art. The technical subject-matter of the prior art must be different. Moreover, it had to be assessed whether publicly accessible information could…

Biologics, Chemical Engineering, EPC, France, Inventive step, Novelty, Procedure, SPC, Validity

(Véron & Associés)/ /1 Comment

H. Lundbeck A/S (hereinafter referred to as Lundbeck) is the holder of European patent EP 0 347 066 entitled “new enantiomers and their isolation”, which designates France and was filed on 1 June 1989; it claims priority of a British patent dated 14 June 1988. The invention relates to the two new enantiomers of the antidepressant drug Citalopram and the use of…

Germany, Novelty

(Krieger Mes Graf & v. der Groeben)/

The Court addresses the issue of potential contradictions between features in the generic part and in the characterizing part of a patent claim and the impact on claim construction. Such contradictions may not be resolved by leaving out the features of the generic part when the claim allows for a claim construction which is free…

Case Law, Inventive step, Novelty, Poland, Sufficiency of disclosure

(Allen & Overy)/

In this case the Court held that a previous patent application and other scientific publications which did not disclose the invention in a manner sufficiently complete for it to be carried out by a person skilled in the art, could not influence the novelty of the invention for which that patent application was later filed….